Effect of Bushen Huoxue Prescription on Cognitive Dysfunction of KK-Ay Type 2 Diabetic Mice

Table 2

Bodyweight in each group after 12 weeks of administration (,  ± s, n = 10).

	Week 0	Week 4	Week 8	Week 12
C58BL/6J	23.58 ± 0.74	27.16 ± 0.46	28.71 ± 1.7	30.10 ± 1.6
KK-Ay	35.33 ± 1.39	44.74 ± 1.39	49.13±±1.34	52.28 ± 1.11
KK-Ay + BSHX 0.5 g/kg	36.41 ± 1.44	45.10 ± 1.14	49.39 ± 1.75	50.38 ± 1.29
KK-Ay + BSHX 1 g/kg	35.88 ± 1.63	45.07 ± 1.2	47.58 ± 1.5	48.39 ± 1.26
KK-Ay + BSHX 2 g/kg	37.07 ± 1.58	43.8 ± 1.7	46.35 ± 1.23	46.28 ± 1.37
KK-Ay + Met 250 mg/kg	35.86 ± 1.92	44.34 ± 2.5	46.41 ± 2.3	47.39 ± 1.35

Data are expressed as mean ± SD (n = 10). vs. the C57BL/6J group. , vs. the KK-Ay group.